Diagnostic Test for Endometrial Receptivity 24 Hours Before Embryo Transfer
Status
Unknown
Conditions
Infertility
Treatments
Other: Day 3 embryo transfer
Other: Day 5 embryo transfer
Details and patient eligibility
About
This clinical validation study is being carried out to validate the efficacy of a test measuring the clinical application of prostaglandins present in the endometrial fluid in patients, 24 hours before the embryonic transfer. This test is capable of predicting endometrial receptivity without the need of performing a biopsy.
Enrollment
120 estimated patients
Sex
Female
Ages
18 to 50 years old
Volunteers
No Healthy Volunteers
Inclusion criteria
- Any IVF patient being treated for single or double embryo transfer
- BMI: 20 - 30
- Normal ovarian response (7 - 8 ovocitos) in IVF treatment with AFC ≥ 8, (AFC = Antral Follicle Count)
- Elective embryo transfer
- Normal uterine cavity
- Age: ≤ 38 years old for patients with own oocytes; ≤ 50 years old for patients with donated oocytes.
Exclusion criteria
- Patients with recurrent miscarriages ( ≥ 2 biochemical miscarriages; ≥ 2 clinical miscarriage)
- Patients with severe male factor ( ≥ 2*106 espermatozoides/ml).
Trial design
Primary purpose
Basic Science
Allocation
Non-Randomized
Interventional model
Parallel Assignment
Masking
None (Open label)
120 participants in 8 patient groups
Day 3 embryo-Own-above cutoff
Experimental group
Description:
Day 3 embryo transfer for IVF with own oocytes, and prostaglandine levels with higher receptivty rates
Treatment:
Other: Day 3 embryo transfer
Day 5 embryo-Own-above cutoff
Experimental group
Description:
Day 5 embryo transfer for IVF with own oocytes, and prostaglandine levels with higher receptivty rates
Treatment:
Other: Day 5 embryo transfer
Day 3 embryo-Donor-above cutoff
Experimental group
Description:
Day 3 embryo transfer for IVF with donor oocytes, and prostaglandine levels with higher receptivty rates
Treatment:
Other: Day 3 embryo transfer
Day 5 embryo-Donor- above cutoff
Experimental group
Description:
Day 5 embryo transfer for IVF with donor oocytes, and prostaglandine levels with higher receptivty rates
Treatment:
Other: Day 5 embryo transfer
Day 3 embryo-Donor-lower cutoff
Experimental group
Description:
Day 3 embryo transfer for IVF with donor oocytes, and prostaglandine levels with lower receptivty rates
Treatment:
Other: Day 3 embryo transfer
Day 5 embryo-Donor-lower cutoff
Experimental group
Description:
Day 5 embryo transfer for IVF with donor oocytes, and prostaglandine levels with lower receptivty rates
Treatment:
Other: Day 5 embryo transfer
Day 3 embryo-own-lower cutoff
Experimental group
Description:
Day 3 embryo transfer for IVF with own oocytes, and prostaglandine levels with lower receptivty rates
Treatment:
Other: Day 3 embryo transfer
Day 5 embryo-own-lower cutoff
Experimental group
Description:
Day 5 embryo transfer for IVF with own oocytes, and prostaglandine levels with lower receptivty rates
Treatment:
Other: Day 5 embryo transfer
Trial contacts and locations
2
Loading...
Central trial contact
Carlos Gómez, MA
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal
© Copyright 2025 Veeva Systems